Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

10nisman,

Good job, jbog - although what is up with the attitude?

My attitude is strictly proportional to your reply to my previous 'thinning out' comment:


Best news I've read in a while. Time for the rest of the shorts to cover. :)

First of all, over many many years of investing I've shorted stocks only a handful of times. I seem to have enough trouble concentrating on picking winners, so I don't think I'd do any better picking losers.

10NIS,

All and all I think Momenta will end up OK, but where we differ is that I think management has to execute it perfectly if we hope Momenta will become a powerhouse one day. So far, I think the complete management team from day one hasn't hit it out of the ballpark.

I'm not sure if you've ever followed PDLI, but in short they were the brains behind the humanization of monoclonal antibodies. They've received billions of dollars in royalties from Avastin, Lucentis, Herceptin, Tysarbri and Xolair.

With the exception of them spinning off their Facet Group (which was bought by Abbott) to thier shareholders, PDLI never really amounted to anything because they were in a perpetual run-off mode. Here was a company that had superior talent and patents and all the street said was that it was going to come to a end, so they never rewarded the stock.

Today, PDLI just basically spits off it's earnings as dividends and the stock is winding down to zero.

Momenta has to set itself apart, and now it has the financial power to do it. Biotech investors only value the future promise.